Beximco Pharmaceuticals Limited reported earnings results for the second quarter and six months ended December 30, 2023. For the second quarter, the company reported sales was BDT 10,904.21 million compared to BDT 9,891.54 million a year ago. Net income was BDT 1,433.47 million compared to BDT 1,237 million a year ago. Basic earnings per share from continuing operations was BDT 3.21 compared to BDT 2.77 a year ago.
For the six months, sales was BDT 22,063.58 million compared to BDT 19,678.74 million a year ago. Net income was BDT 2,986.38 million compared to BDT 2,684.03 million a year ago. Basic earnings per share from continuing operations was BDT 6.69 compared to BDT 6.02 a year ago.